Molecular biology reportsOct 7, 2026

Mitochondria problems in kidney tubule cells linked to scarring and tissue changes in chronic kidney disease

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Oct 8, 2026

Abstract

Chronic kidney disease (CKD) is associated with renal fibrosis, which contributes to progressive loss of kidney function.

Renal tubular epithelial cells, especially proximal tubular epithelial cells, rely heavily on oxidative metabolism and are susceptible to various stressors.
Persistent mitochondrial injury in these cells can lead to several disruptions, including decreased fatty acid oxidation and increased reactive oxygen species.
These mitochondrial dysfunctions can result in maladaptive repair processes, cell senescence, and inflammatory cell death.
Fibrotic remodeling in CKD is influenced by paracrine signaling to various cell types, including fibroblasts and macrophages.
Mitochondrial dysfunction is recognized as a context-dependent factor that contributes to CKD-associated fibrosis rather than being a universal trigger.
Challenges in translating mitochondrial-targeted therapies into clinical practice include disease heterogeneity and a lack of validated antifibrotic endpoints.

Simplified

Chronic kidney disease (CKD) is a major global health burden, and renal fibrosis is a common pathological correlate of progressive loss of kidney function. Renal tubular epithelial cells (RTECs), particularly proximal tubular epithelial cells (PTECs), contain abundant mitochondria and depend on oxidative metabolism to support solute transport. This metabolic specialization renders them vulnerable to hypoxia, lipotoxicity, uremic toxins, aging, inflammation, and hemodynamic stress. Persistent mitochondrial injury can suppress fatty acid oxidation and oxidative phosphorylation, deplete nicotinamide adenine dinucleotide, increase mitochondrial reactive oxygen species, destabilize mitochondrial DNA, and disrupt biogenesis, dynamics, mitochondria-associated membrane signaling, and mitophagy. These abnormalities promote maladaptive repair, senescence, inflammatory cell death, and paracrine signaling to fibroblasts, macrophages, endothelial cells, and pericytes. Evidence is organized within a tubule-to-niche framework that distinguishes causal perturbation from temporal or transcriptomic association, model-specific findings from cross-model convergence, and experimental efficacy from clinical translation. Single-cell, spatial, and organoid studies are considered alongside evidence from human biopsy specimens and biomarkers. Mitochondrial dysfunction is thus treated as a context-dependent contributor to, and amplifier of, CKD-associated fibrotic remodeling rather than a universal initiating event. Although strategies targeting bioenergetics, redox balance, mitochondrial quality control, and tubular delivery are promising, translation is constrained by disease heterogeneity, intervention timing, target specificity, pharmacokinetics, and the scarcity of validated human antifibrotic endpoints.

Full Text

Full text is available at the source.

View Full Text ↗

Mitochondria problems in kidney tubule cells linked to scarring and tissue changes in chronic kidney disease

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the longevity & aging brief